Načítá se...

Bevacizumab or laser for aggressive posterior retinopathy of prematurity

PURPOSE: The purpose of this study was to report the rate of reactivation and structural outcome, after the laser or bevacizumab treatment for aggressive posterior retinopathy of prematurity (APROP). METHODS: Retrospective chart review was conducted on consecutive infants with APROP treated with (1)...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Taiwan J Ophthalmol
Hlavní autoři: Blair, Michael, Gonzalez, Jose Maria Garcia, Snyder, Laura, Schechet, Sidney, Greenwald, Mark, Shapiro, Michael, Rodriguez, Sarah Hilkert
Médium: Artigo
Jazyk:Inglês
Vydáno: Medknow Publications & Media Pvt Ltd 2018
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6302568/
https://ncbi.nlm.nih.gov/pubmed/30637196
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/tjo.tjo_69_18
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!